Target intelligence / Profile preview

DNA crosslink

Molecular classification
Other
01

Overview

DNA crosslinks are covalent bonds formed between two nucleotides within the same strand (intrastrand) or across opposite strands (interstrand) of double-stranded DNA. These lesions can be caused by exogenous agents such as chemotherapeutic drugs (e.g., cisplatin, melphalan, mitomycin C), environmental toxins, or endogenous metabolic products. Crosslinks block essential cellular processes like replication and transcription; if unrepaired, they trigger cell death through apoptosis. This property is exploited in cancer chemotherapy to selectively kill rapidly dividing tumor cells. However, the process itself is not a discrete molecular target such as a receptor or enzyme but rather a type of chemical damage induced in the genome[2][4]. Therefore, "DNA crosslinking causing apoptosis" describes a mechanism or effect rather than an individual molecular entity that can be directly targeted by drugs. **Note:** There is something incorrect with this entry as it refers to a process/mechanism ("DNA crosslinking causing apoptosis") rather than an individual molecule/receptor/target protein. The canonical form should refer to specific enzymes involved in repair pathways or specific drug targets that induce this effect—not the process itself[2][4].

Other names
DNA interstrand crosslinkDNA intrastrand crosslinkDNA-protein crosslinkICL (interstrand crosslink)
02

Mechanism of action

Induction of apoptosis via inhibition of DNA replication and transcription by covalent linkage between nucleotides[2][4]

03

Biological functions

Cell deathApoptosisInhibition of DNA replication and transcription
04

Disease associations

Cancer (as a therapeutic target/process)
05

Safety considerations

Off-target cytotoxicity to healthy cells[1][3]
06

Interacting drugs

Cisplatin

3 more in the full profile.

Beyond the preview

Go deeper on DNA crosslink.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA crosslink.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call